http://www.acc.org/Feed?clinicalTopicID=c6941522-1083-4553-8e5e-cf55e1225c0c Clinical Topic Feed: Anticoagulation Management and Venothromboembolism en /Latest-in-Cardiology/Articles/2026/02/24/16/30/eagles-eye-view-24feb2025 In this week’s View, Dr. Eagle looks at findings from the Evolut Low Risk trial in which self-expanding transcatheter aortic valve replacement (TAVR) versus surgery at six years in low-risk patients with aortic stenosis (AS) is considered. 1772031600000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/02/17/14/32/ACC-AHA-Release-First-Ever-Guideline-For-Treatment-and-Management-of-Acute-PE The new ACC/AHA Guideline for the Evaluation and Management of Acute Pulmonary Embolism (PE) in Adults is a de novo document offering comprehensive, evidence‑based recommendations for the evaluation, management and follow‑up of adults with acute PE. 1771527600000 Articles and Stories /Latest-in-Cardiology/Articles/2025/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1746101460000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/02/25/16/15/State-of-the-Art-Review-Shares-Insights-on-VTE-Treatment-Advancements A State-of-the-Art Review published on Feb. 26 in JACC: Basic to Translational Science highlights the potential of emerging thrombolytic therapies such as antagonists of fibrinolysis inhibitors to improve safety and efficacy of the treatment and prevention of acute thrombosis in patients with venous thromboembolism (VTE). 1740599760000 Articles and Stories /Latest-in-Cardiology/Articles/2025/01/14/14/38/Rivaroxaban-Beyond-6-Weeks The optimal management of isolated, distal deep vein thrombosis (DVT) remains unclear. Data from recent studies suggest that certain patients may benefit from anticoagulation... 1736887260000 Articles and Stories /Latest-in-Cardiology/Articles/2024/11/27/14/19/eagles-eye-view-27nov2024 In this week’s View, Dr. Eagle looks at the prevalence of overweight and obesity among children, adolescents, and adults in the U.S., with forecasts up to 2050. 1732719600000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2024/11/22/18/26/bleeding-risk-using What is the bleeding risk of nonsteroidal anti-inflammatory drug (NSAID) use in addition to oral anticoagulants (OACs) for the treatment of venous thromboembolism (VTE)? 1732302180000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2024/08/20/16/37/low-dose-rivaroxaban What are the safety and efficacy outcomes of rivaroxaban 2.5 mg twice daily plus aspirin in fragile patients undergoing lower extremity revascularization? 1724179860000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2024/03/25/15/50/targeted-prophylactic-anticoagulation What is the safety of withholding anticoagulation for patients with lower limb trauma at low risk for venous thromboembolism (VTE), as defined by the TRiP(cast) score? 1711385700000 Articles and Stories /Latest-in-Cardiology/Articles/2023/08/31/11/58/Antithrombotic-Therapy-in-Athletes Antithrombotic agents provide critical protective benefits to individuals with cardiovascular (CV) disease, but the associated bleeding risk is particularity concerning for athletes and highly active individuals. 1693499580000 Articles and Stories